geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year


, : Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Archives of Neurology 68(6): 779-786

To characterize the short-term course of spinal muscular atrophy (SMA) in a genetically and clinically well-defined cohort of patients with SMA. A comprehensive multicenter, longitudinal, observational study. The Pediatric Neuromuscular Clinical Research Network for SMA, a consortium of clinical investigators at 3 clinical sites. Sixty-five participants with SMA types 2 and 3, aged 20 months to 45 years, were prospectively evaluated. We collected demographic and medical history information and determined the SMN 2 copy number. Clinical outcomes included measures of motor function (Gross Motor Function Measure and expanded Hammersmith Functional Motor Scale), pulmonary function (forced vital capacity), and muscle strength (myometry). Participants were evaluated every 2 months for the initial 6 months and every 3 months for the subsequent 6 months. We evaluated change over 12 months for all clinical outcomes and examined potential correlates of change over time including age, sex, SMA type, ambulatory status, SMN2 copy number, medication use, and baseline function. There were no significant changes over 12 months in motor function, pulmonary function, and muscle strength measures. There was evidence of motor function gain in ambulatory patients, especially in those children younger than 5 years. Scoliosis surgery during the observation period led to a subsequent decline in motor function. Our results confirm previous clinical reports suggesting that SMA types 2 and 3 represent chronic phenotypes that have relatively stable clinical courses. We did not detect any measurable clinical disease progression in SMA types 2 and 3 over 12 months, suggesting that clinical trials will have to be designed to measure improvement rather than stabilization of disease progression.

US$19.90

PMID: 21320981

DOI: 10.1001/archneurol.2010.373


Other references

Chung, J.H.; Kim, K.H.n; Koh, W.S.ok; Park, K.C.an, 1993: Comparative study for the differentiation of allergic and irritant contact dermatitis in mice. Our study was performed to compare the differences between allergic and irritant contact dermatitis in BALB/c mice. Allergic reaction was induced by a sensitizing regimen of 2,4-dinitro-1-fluorobenzene (DNFB) and irritant reaction by 10% sodium la...

Sonoda, D.Y.; Conte, L.; Scorvo Filho, J.D.; Shirota, R.; Possebon Cyrino, J.E., 2002: A comparative analysis of the commercialisation of fishing by CEAGESP fishing company in Brazil in the 1980s and 1990s. The CEAGESP fishing company, based in Sao Paulo, handles around 7.5% of fish caught in Brazil, of which 6.5% is freshwater fish. The annual catch fell from 700 000 tons in the 1980s to <600 000 tons in the 1990s, when only 6.4% of the catch of...

Sun, Y.; Wang, M.; Li, L.; Zhou, L.; Wang, X.; Zheng, P.; Yu, H.; Li, C.; Sun, S., 2017: Molecular identification of methane monooxygenase and quantitative analysis of methanotrophic endosymbionts under laboratory maintenance in iBathymodiolus platifrons from the South China Sea. Deep-sea mussels of the genus <i>Bathymodiolus</i> are numerically dominant macrofauna in many cold seep and hydrothermal vent ecosystems worldwide, and they depend on organic carbon produced by symbionts present in the epithelial cell...

Sun, X.; Zhang, H-Wei.; Zhang, Z-Rong., 2009: Growth inhibition of the pulmonary metastatic tumors by systemic delivery of the p27 kip1 gene using lyophilized lipid-polycation-DNA complexes. p27(kip1) (p27), a cyclin-dependent kinase inhibitor (CDKI), is an important regulator of cell cycle progression and a putative tumor suppressor gene, and plays an important role in the inhibition of genesis and progression of several kinds of can...

Mcbride J.E.; Kirkpatrick R.L.; Ney J.J.; Tipton A.R., 1981: Genetic investigation of endrin resistance in pine voles microtus pinetorum using starch gel electrophoresis. Virginia Journal of Science 32(3): 95

Stahl Hennig, C.; Stolte, N.; Ueberla, K.; Steinman, R.; Ignatius, R.; Tenner Racz, K.; Racz, P., 2001: Protection against vigorous oral SIV challenge in macaques immunized by different routes with live, attenuated SIV. Journal of Medical Primatology 30(4): 231, August

Endevelt, R.; Elkayam, O.; Cohen, R.; Peled, R.; Tal-Pony, L.; Michaelis Grunwald, R.; Valinsky, L.; Porath, A.; Heymann, A.David., 2015: An intensive family intervention clinic for reducing childhood obesity. Childhood and adolescent obesity constitute a significant public health concern. Family health care settings with multidisciplinary teams provide an opportunity for weight loss treatment. The objective of this study was to examine the effect of in...

Lipparoni, E., 1957: Sopra alcuni esemplaii femmine di anchilostoma, riportabile ad A. iperodontatum, parassita di Caracal nubicus. Lipparoni describes the female of Ancylostoma iperodontatum Le Roux & Biocca, 1957, four specimens of which were found in the small intestine of Caracal nubicus near Villagio Duca dcgli Abruzzi (Somalia) in 1951. This is said to be a new host reco...

Zhi Xiachen; Reisberg Laurie; X.X.sheng, 2007: Re-Os systematics of lithospheric peridotites from Nushan, east China; implications for multiple modifications of SCLM. Geochimica et Cosmochimica Acta 71(15S): A1168

Pilling, S.; Gould, N.; Whittington, C.; Taylor, C.; Scott, S.; Scott, S.; Gould, N.; Pilling, S.; Whittington, C.; Anderson, B.; Anigbogu, B.; Barratt, S.; Braidwood, R.; Brewster, M.; Compitus, B.; Doolan, M.; Fonagy, P.; Gibbon, L.; Glover, N.; Harrison, B.; Kaminski, F.; Keen, D.; McArdle, P.; Mitchell, P.; Moulin, M.; Nieto-Hernandez, R.; Smith, M.; Stockton, S.; Taylor, C.; Taylor, J.; Williams, P.; Wootton, T.; Yesufu-Udechuku, A., 2013: Recognition, intervention, and management of antisocial behaviour and conduct disorders in children and young people: summary of NICE-SCIE guidance. Antisocial behaviour and conduct disorders (including oppositional defiant disorder and conduct disorder) are the most common mental and behavioural problems in children and young people globally.